TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.40$ -5.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NRXS
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +2.6% +1.2% +9.7% -7.1% +57.3%
– -0.3% -43.8% +2,645.3% +87.2% -57.5%
– – – – – –
– – +97.1% -152.4% – +331.5%
– -95.0% +4,303.2% +17.3% -61.3% +12.1%
– -95.0% +4,303.2% +17.3% -61.3% +372.2%
– – +1,990.6% -34.6% +125.5% -106.0%
– -89.1% +246.7% +187.5% +47.9% -19.6%
– -183.4% – – – -65.0%
– – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?